Overview

• President Claudia Sheinbaum said national medicine availability is roughly 90%, with shortages linked to contractors that failed to meet the centralized purchase commitments.
• Penalties under review include contract termination, possible inhabilitations and re‑tendering through reverse auctions to replace noncompliant suppliers.
• Health undersecretary Eduardo Clark previously named 32 companies with partial or total non‑deliveries ahead of the Sept. 30 cutoff.
• Industry associations Amelaf and Canifarma contend that firms are delivering but allege at least 14 billion pesos in unpaid government debts dating to 2021.
• While reviews continue, Birmex awarded a 73.279 million‑peso distribution contract on Sept. 26 to Médica Farma Arcar for nine IMSS‑Bienestar states, despite ASF findings of unverified 2023 payments that triggered administrative probes.